Flexibility, Resistance, Aerobic, Movement Execution (FRAME) Training Program to Improve Gait Capacity in Adults With Hereditary Spastic Paraplegia: Protocol for a Single-cohort Feasibility Trial

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Hereditary Spastic Paraplegia (HSP) is a diverse group of genetic neurological conditions causing progressive weakness and spasticity in the lower limbs, severely reducing balance and gait capabilities. There is currently a lack of structured neurorehabilitation programs aimed at improving gait in adults with HSP. This protocol seeks to assess the feasibility and effectiveness of a structured training approach focusing on flexibility, muscle strength, motor control, balance, and aerobic capacity. To this end, twenty adults diagnosed with HSP will engage in 10 to 16 sessions, each lasting 60 to 120 minutes, guided by a therapist once or twice a week, depending on individual preferences. At the end of the program, participants will receive a transfer package, including written instructions (a manual) and video tutorials, to encourage ongoing exercise at home. Assessments will occur before the intervention (T0), immediately after (T1), and three months later (T2). The primary outcomes will measure the feasibility of the program, including recruitment, retention, adherence, the absence of adverse events, and patient satisfaction. Secondary outcomes will focus on improvements in gait capabilities such as gait endurance and gait speed.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Adults diagnosed with Hereditary Spastic Paraplegia.

• Presence of any functional deficit in the lower limbs that affects walking, such as muscle weakness, hypertonia, or balance issues.

• Ability to walk without the need for physical contact with another person, as defined by a Functional Ambulation Category score of 3 or higher.

• Ability to understand simple instructions, comprehend the purpose of the study, willingness to participate and undergo at least 10 treatment sessions, eligible and willing to sign the informed consent.

Locations
Other Locations
Italy
Scientific Institute, IRCCS E. Medea, Department of Bosisio Parini, Lecco, Italy.
RECRUITING
Bosisio Parini
Scientific Institute, IRCCS E. Medea, Department of Pieve di Soligo, Treviso, Italy
RECRUITING
Pieve Di Soligo
Contact Information
Primary
Leonardo Boccuni, PhD
leonardo.boccuni@lanostrafamiglia.it
003904384141
Backup
Marco Bortolini, BSc
marco.bortolini@lanostrafamiglia.it
003904389062
Time Frame
Start Date: 2024-12-23
Estimated Completion Date: 2027-04
Participants
Target number of participants: 20
Treatments
Experimental: HSP Cohort
The whole cohort of HSP patients will receive the same comprehensive neurorehabilitation program aiming at improving gait capabilities (speed and endurance). The content and the dosis of the treatment will be personalized according to patient's specific needs and preferences.
Sponsors
Leads: IRCCS Eugenio Medea

This content was sourced from clinicaltrials.gov